###begin article-title 0
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells
###end article-title 0
###begin p 1
###xml 34 57 34 57 <email xmlns:xlink="http://www.w3.org/1999/xlink">bart.lambrecht@ugent.be</email>
CORRESPONDENCE Bart N. Lambrecht: bart.lambrecht@ugent.be
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 164 165 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 312 313 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 318 320 318 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 494 495 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 500 502 500 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 567 568 567 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 705 706 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 714 715 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 763 764 759 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 772 773 764 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 827 829 819 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 861 862 853 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 867 868 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 873 875 865 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1004 1005 996 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1122 1123 1114 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1129 1132 1121 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 961 965 <span type="species:ncbi:10090">mice</span>
###xml 1301 1305 <span type="species:ncbi:10090">mice</span>
Although dendritic cells (DCs) play an important role in mediating protection against influenza virus, the precise role of lung DC subsets, such as CD11b- and CD11b+ conventional DCs or plasmacytoid DCs (pDCs), in different lung compartments is currently unknown. Early after intranasal infection, tracheal CD11b-CD11chi DCs migrated to the mediastinal lymph nodes (MLNs), acquiring co-stimulatory molecules in the process. This emigration from the lung was followed by an accumulation of CD11b+CD11chi DCs in the trachea and lung interstitium. In the MLNs, the CD11b+ DCs contained abundant viral nucleoprotein (NP), but these cells failed to present antigen to CD4 or CD8 T cells, whereas resident CD11b-CD8alpha+ DCs presented to CD8 cells, and migratory CD11b-CD8alpha- DCs presented to CD4 and CD8 T cells. When lung CD11chi DCs and macrophages or langerin+CD11b-CD11chi DCs were depleted using either CD11c-diphtheria toxin receptor (DTR) or langerin-DTR mice, the development of virus-specific CD8+ T cells was severely delayed, which correlated with increased clinical severity and a delayed viral clearance. 120G8+ CD11cint pDCs also accumulated in the lung and LNs carrying viral NP, but in their absence, there was no effect on viral clearance or clinical severity. Rather, in pDC-depleted mice, there was a reduction in antiviral antibody production after lung clearance of the virus. This suggests that multiple DCs are endowed with different tasks in mediating protection against influenza virus.
###end p 3
###begin p 4
###xml 277 282 <span type="species:ncbi:10090">mouse</span>
Abbreviations used: BAL, bronchoalveolar lavage; cDC, conventional DC; dpi, days postinfection; DTR, diphtheria toxin receptor; HA, hemagglutinin; HI, HA inhibition; i.n., intranasal; i.t., intratracheal; MFI, mean fluorescence intensity; MLN, mediastinal lymph node; mPDCA-1, mouse pDC antigen 1; NP, nucleoprotein; pDC, plasmacytoid DC; Tg, transgenic.
###end p 4
###begin p 5
G.F. Rimmelzwaan and B.N. Lambrecht contributed equally to this paper.
###end p 5
###begin p 6
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">.</italic>
Influenza type A is a cytolytic virus that causes acute respiratory infection, of which the clinical outcome can vary greatly. The way in which the innate and adaptive immune systems initially recognize and deal with replicating virus could be decisive in determining the outcome of infection, as this might heavily influence the kinetics of viral clearance (1-3). Little is known about the initial recognition event of influenza virus by the lung immune system in vivo.
###end p 6
###begin p 7
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 858 859 858 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
In immediate response to viral infection, innate defense mechanisms consist of high level production of type I IFNs by infected epithelial cells, alveolar macrophages, and natural IFN-producing cells (also known as preplasmacytoid DCs [pre-pDCs]), as well as the recruitment of conventional DCs (cDCs), neutrophils, and NK cells (4, 5). By expressing a wide array of microbial pattern recognition receptors shared with cells of the innate immune response, and at the same time displaying the potential to process and present antigen to naive T cells, DCs bridge innate and adaptive immunity. After recognizing foreign antigen in the periphery of the body, DCs migrate via afferent lymphatics into the draining LNs, where they can induce antigen-specific protective CD8 CTL responses, as well as CD4 T helper cells that enforce cellular and humoral immunity (6).
###end p 7
###begin p 8
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 755 757 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 809 810 809 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 815 816 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 821 822 821 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1028 1030 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 1032 1034 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 1124 1125 1124 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1135 1136 1135 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 1219 1221 1219 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1259 1261 1259 1261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1331 1333 1331 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 1350 1351 1350 1351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1356 1359 1356 1359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1484 1486 1484 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 1488 1490 1488 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 1668 1670 1664 1666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1672 1673 1668 1669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 1837 1839 1833 1835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1840 1842 1836 1838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 345 350 <span type="species:ncbi:10090">mouse</span>
###xml 1443 1448 <span type="species:ncbi:10090">mouse</span>
In the lung, DCs are situated in immediate proximity to the respiratory epithelial cells, where they form an elaborate network that rapidly reacts to all kinds of foreign antigens and inflammatory stimuli, including respiratory viruses (7-10). Different DC subsets can be found in the lung, each with a functional specialization (11-15). In the mouse, all DC subsets express the integrin CD11c, and subsets are further defined based on the expression of the marker CD11b, as well as anatomical location (11, 13, 16). The trachea and large conducting airways have a well-developed network of intraepithelial DCs, even in steady-state conditions (17, 18). These cells have been shown to express langerin and CD103 while lacking expression of CD11b (13, 10, 15). In the submucosa of the conducting airways, CD103-CD11b+CD11c+ cDCs can be found, particularly under conditions of inflammation, and these cells might be particularly suited for priming and restimulating effector CD4 cells in the lung in response to protein antigens (19, 20, 15). The lung interstitium that is accessible by enzymatic digestion also contains CD11b+ and CD11b- DCs that access the alveolar lumen and migrate to the mediastinal LNs (MLNs) (14, 11). In the nearby alveolar lumen, CD11chi alveolar macrophages control the function of these interstitial DCs (21). pDCs are CD11b-CD11cint cells expressing SiglecH and bone marrow stromal antigen 2 (recognized by the mAbs mouse pDC antigen 1 [mPDCA-1] or 120G8) (22, 23). In the lungs, pDCs are predominantly found in the lung interstitium and produce large amounts of IFN-alpha in response to triggering by CpG motifs or viral infection ex vivo (24, 5). Under particular conditions, lung pDCs can prevent immunopathology in response to inhalation of harmless antigens or in response to respiratory syncitial virus (24-26).
###end p 8
###begin p 9
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 556 558 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 560 562 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 563 565 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 705 707 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 709 711 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 749 751 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 186 191 <span type="species:ncbi:10090">mouse</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 571 577 <span type="species:ncbi:9606">humans</span>
Several investigators have studied the involvement of APCs such as DCs, macrophages, and B cells in mediating protective immunity to influenza virus (27). It was previously shown that a mouse-adapted strain of influenza virus induced the in vivo maturation of CD11c+ DCs in the lung (28) and their migration to the MLNs (29, 8, 2). DCs isolated ex vivo from the MLNs of influenza-infected mice presented viral nucleoprotein (NP)-derived peptides to virus-specific CD8 T cells in vitro for at least 10 d, a peak occurring approximately72 h after infection (27, 29-32). In humans, both monocyte-derived DCs and pDCs were shown to be capable of activating already primed influenza-specific T cells in vitro (33, 34) and upon adoptive transfer in vivo (35).
###end p 9
###begin p 10
###xml 574 575 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 585 586 585 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 813 815 813 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 847 848 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 853 855 853 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 945 947 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 107 124 <span type="species:ncbi:11320">influenza A virus</span>
###xml 935 939 <span type="species:ncbi:10090">mice</span>
Although these studies certainly suggest the strong involvement of DCs in mediating protective immunity to influenza A virus, direct description of the functional in vivo involvement of the now well-described DC subsets in the different compartments of the lung during early infection is lacking. In this paper, using eight-color flow cytometry, we have carefully studied the kinetics of the reaction of different DC subsets and alveolar macrophages in various lung compartments to intranasal (i.n.) infection with influenza virus X-31 (H3N2), focusing particularly on CD11b+ and CD11b- subsets, as well as on pDCs, describing which subsets carry viral NP to the nodes, and carefully dissecting which subsets present antigen to specific CD8 and CD4 T cells. Using genetic cell-specific targeting techniques, CD11chi DCs and macrophages or langerin+CD11chi DCs could be depleted in CD11c-diphtheria toxin receptor (DTR) or langerin-DTR mice (36, 37), and pDCs could be depleted using mAbs. Collectively, our results demonstrate that different DC subsets perform specialized tasks during the primary encounter with influenza virus in the lung.
###end p 10
###begin title 11
RESULTS
###end title 11
###begin title 12
Lung DC subtypes and alveolar macrophages respond to influenza virus infection differentially
###end title 12
###begin p 13
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 65 67 65 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 352 353 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 424 425 424 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 918 920 918 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 927 929 927 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 935 937 935 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 994 995 994 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1004 1005 1004 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1013 1015 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1017 1019 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 1021 1023 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 1115 1117 1115 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1124 1126 1124 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1131 1134 1131 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1140 1143 1140 1143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1151 1152 1151 1152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1176 1178 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1300 1302 1300 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1309 1311 1309 1311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1318 1320 1318 1320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1327 1329 1327 1329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1552 1554 1552 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 1556 1558 1556 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 1560 1562 1560 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 68 85 <span type="species:ncbi:11320">influenza A virus</span>
As expected after i.n. inoculation with 5 x 105 tissue culture ID50 influenza A virus X-31 (H3N2), there was induction of vigorous innate and adaptive immune responses in the lung. The innate cellular immune response was already present 1 day postinfection (dpi) and peaked at 4 dpi, exemplified by a strong increase in neutrophils. B lymphocytes (CD19+) were present in the lung by day 4 and peaked around day 10. Total CD8+ cells in the lung peaked around day 10 (Fig. S1, available at ). To investigate the number of DC subsets and macrophages after influenza virus infection, enzymatically digested lungs (from which the large conducting airways were dissected) were analyzed at different time points after infection by eight-color flow cytometry. Digested lung cells were first gated for live leukocytes and expression of the panleukocyte marker CD45. cDCs were characterized as low fluorescent cells, with a CD45hi, MHCIIhi CD11chi phenotype (Fig. S2 A), and further subdivided into CD11b+ or CD11b- cells (11, 15, 30, 13). As previously described, pDCs were small, low autofluorescent cells expressing a CD45hi, CD11blo, MHCint CD11cint mPDCA-1+ phenotype (Fig. S2 B) (24). Alveolar macrophages were identified in the bronchoalveolar lavage (BAL) fluid as highly fluorescent cells with a CD11chi, CD11blo, MHCIIlo, F4/80hi phenotype (Fig. S2 C). The use of CD11c and CD11b expression in combination with the autofluorescence typically seen in alveolar macrophages adequately discriminated alveolar DCs from macrophages, as previously described (38, 39, 11).
###end p 13
###begin p 14
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 157 165 157 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 176 177 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 179 187 179 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 371 386 371 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A and B</xref>
###xml 618 633 618 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A and B</xref>
###xml 761 769 761 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 1194 1202 1194 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
In the mock situation, 65% of CD11chi DCs were CD11b- and 35% were CD11b+. After infection with influenza virus X-31, a significant increase in both CD11b+ (Fig. 1 A) and CD11b- (Fig. 1 B) lung DCs was seen from 2 dpi, and these DC subsets remained increased up to at least 10 dpi. The DCs expressed high levels of MHCII and up-regulated maturation markers such as CD86 (Fig. 1, A and B), CD40, CD80, and intercellular adhesion molecule 1 (not depicted). The increase in the expression level of these markers peaked shortly after inoculation (2 d) and gradually returned back to the levels seen in mock-infected mice (Fig. 1, A and B, bar graphs). In contrast, the number of pDCs peaked shortly after infection (2 dpi) and then returned to baseline conditions (Fig. 1 C). This increased recruitment of pDCs was accompanied by a distinct but very transient up-regulation of maturation markers (CD86 is shown). Alveolar macrophages were studied in the BAL fluid accessible by BAL. This compartment contains a large amount of resident alveolar macrophages in mock situation. After influenza virus infection, there was a nonsignificant trend of increase in the alveolar macrophage number at 4 dpi (Fig. 1 D), accompanied by a temporary increase in CD86 and a more continual increase in MHCII expression (mean fluorescence intensity [MFI] of 820 in mock and 2,769 at 10 dpi).
###end p 14
###begin p 15
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Number and surface phenotype of mouse lung CD11b<sup>+</sup> and CD11b</bold>
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 60 122 60 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DCs, pDCs, and alveolar macrophages after influenza infection.</bold>
###xml 255 256 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
###xml 972 976 <span type="species:ncbi:10090">mice</span>
Number and surface phenotype of mouse lung CD11b+ and CD11b-DCs, pDCs, and alveolar macrophages after influenza infection. Populations were gated as shown in Fig. S2 (available at ) and as indicated by the gates in the left column of each panel. (A) CD11b+ DCs significantly increased after infection and remained increased up to 10 dpi (left). CD86 expression was plotted in histograms (right), with MFI shown in the graph (bottom). (B) The increase in CD11b- DCs is demonstrated in flow cytometric plots (left), with absolute numbers shown in the graph (bottom). CD86 expression was up-regulated and plotted as MFI (C, bottom). pDCs increased significantly at 2 dpi and then returned to baseline. Recruitment of pDCs was accompanied by up-regulation of CD86 (right). (D) Alveolar macrophages slightly increased in number, but CD86 expression was not increased. Gray histograms represent isotype controls and were measured at 4 dpi. The values are representative of five mice per group and are expressed as mean +/- SEM. Similar results were obtained from at least three separate experiments. *, P < 0.05; **, P < 0.01.
###end p 15
###begin title 16
Response of DC subsets in the large conducting airways to influenza virus infection
###end title 16
###begin p 17
###xml 292 300 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 350 351 350 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 794 802 794 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 836 837 836 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 843 844 843 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 950 951 938 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 983 984 967 968 <sub xmlns:xlink="http://www.w3.org/1999/xlink">E</sub>
###xml 1008 1016 992 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1230 1245 1214 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, B and C</xref>
###xml 1325 1326 1309 1310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1341 1349 1325 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1395 1396 1379 1380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1406 1407 1390 1391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1571 1573 1555 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1635 1636 1619 1620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1659 1660 1643 1644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1709 1717 1693 1701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 1849 1857 1833 1841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 1703 1707 <span type="species:ncbi:10090">mice</span>
To examine the DC network in the large conducting airways, we stained in vivo fixed and permeabilized tracheal whole mounts with an mAb to MHCII, revealing the presence of a highly developed network of DCs and demonstrating delicate dendritic processes in between bronchial epithelial cells (Fig. 2 A). After infection, there was an increase in MHCII+ cells at 2 dpi, and cells had a more rounded appearance, making it difficult to quantify DC density. At 4 dpi, there was a strong decrease in the density of cells staining for MHCII, followed by a restoration to baseline density and morphology by 10 dpi. To better quantify these changes, eight-color flow cytometry was performed on tracheal digestions, demonstrating considerable heterogeneity in DCs at various time points after infection (Fig. 2 B). In the mock situation, all CD45+ MHCII+ cells expressed CD11c, identifying them as DCs. The majority of these cells (approximately75%) were CD11b- and expressed the mucosal alphaE integrin marker CD103 (Fig. 2 C). At 2 dpi, this subset was depleted from the tracheal digest and a majority of cells now expressed CD11b but lacked CD103, which was most consistent with the phenotype of a freshly recruited monocyte-derived DC (Fig. 2, B and C). A temporary increase in the expression level of CD86 was found on these CD11b+ DCs at day 2 (Fig. 2 B). At 10 dpi, the subset balance between CD11b+ and CD11b- DCs was almost restored to baseline, and cells again showed a highly dendritic morphology and CD86 expression returned to baseline levels. As previously reported (11), we detected a minor percentage (0.35% of live tracheal CD45+ leukocytes) of mPDCA-1+ pDCs in tracheal digests of mock-infected mice (Fig. 2 D). Again, pDCs increased after influenza virus infection and temporarily up-regulated their expression of co-stimulatory molecules (Fig. 2 E).
###end p 17
###begin p 18
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DC subtypes in tracheal tissue after influenza infection.</bold>
###xml 302 303 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 342 343 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 363 364 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 686 689 683 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 695 696 692 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 742 743 739 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
DC subtypes in tracheal tissue after influenza infection. (A) Tracheal whole mount sections stained for MHCII expression were performed at various days after infection. Bar, 35 mum. (B) Flow cytometric analysis of DCs in tracheal cell suspensions stained for CD45, CD11c, CD11b, F4/80, and CD103. CD11c+ cells contained two subsets, one CD11b- and the other CD11b+. Histograms represent CD86 expression on both subsets. The dotted lines indicate MFI in a mock situation. (C) Absolute numbers of the two subsets after influenza infection expressed as mean values +/- SEM. *, P < 0.05; **, P < 0.01. Histograms represent CD103 expression on both subsets. (D) pDCs were identified as CD11cintPDCA-1+ cells representing a minor percentage of CD45+ leukocytes in tracheal cell suspensions and only temporarily expressing CD86 (histogram). (E) Absolute number of pDCs at various days after infection expressed as mean values +/- SEM. **, P < 0.01.
###end p 18
###begin title 19
Influenza virus infection increases DC subsets in MLNs
###end title 19
###begin p 20
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 214 215 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 223 231 223 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 314 322 314 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 395 396 395 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 407 408 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 418 419 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 424 425 424 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 504 505 504 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 530 531 530 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 536 538 536 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 622 623 622 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 649 650 649 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 745 746 745 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 754 755 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 847 848 843 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 853 854 849 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 901 903 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 969 977 961 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 1071 1072 1059 1060 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1087 1088 1075 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1098 1099 1086 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1131 1132 1115 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1137 1138 1121 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1185 1186 1169 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1191 1192 1175 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1354 1362 1338 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
###xml 1275 1279 <span type="species:ncbi:10090">mice</span>
Upon recognition of antigen, lung DCs are known to migrate to the MLNs. We followed the kinetics of increase and expression of maturation markers on various DC subsets within this node. cDC subsets were CD11c+MHCII+ cells (Fig. 3 A) that were further discriminated based on expression of the myeloid marker CD11b (Fig. 3 B). After infection, there was an increase in the absolute amount of CD11c+MHCII+CD11b- and CD11c+MHCII+CD11b+ DCs starting at 2 dpi, and the increase was more pronounced in the CD11b+ subset. Within the CD11b-CD11chi cells, there was a clear increase in cells coexpressing langerin and CD103 (30 x 104 cells at 4 dpi vs. 2 x 104 cells in mock-infected mice). Belz et al. previously suggested that a resident subset of CD11b-CD8alpha+ DCs was responsible for generating virus-specific CD8 CTLs, whereas the population of CD11b-CD11c+ cells transported antigen from the periphery (30). Therefore, cells were further discriminated based on CD8alpha (Fig. 3 C). Compared with mock-infected mice, at 4 dpi there was a generalized increase in all CD8alpha- subsets (CD11b- and CD11b+), whereas the resident CD8alpha+CD11b- DCs were not increased. After infection, CD11c+MHCII+ cells had higher levels of the CD86 maturation marker compared with mock-infected mice, which was consistent with their potential to prime CD8 T cell responses (Fig. 3 D), and this was found in all DC subsets.
###end p 20
###begin p 21
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DC subsets in MLNs after influenza virus infection.</bold>
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 215 216 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1630 1631 1619 1620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1656 1657 1645 1646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 1340 1344 <span type="species:ncbi:10090">mice</span>
###xml 1615 1619 <span type="species:ncbi:10090">mice</span>
DC subsets in MLNs after influenza virus infection. (A) Kinetics of CD11c+MHCII+ DCs demonstrating an almost fourfold increase after infection. Percentages of living cells are shown. (B) Expression of CD11b by CD11c+ DCs gated in A. The values are representative of five mice per group and are expressed as mean +/- SEM. Similar results were obtained from separate experiments. (C) CD8alpha expression on different DC subsets was demonstrated in combination with CD11b, with percentages of the different populations plotted in the graph. The values are representative of five mice per group and are expressed as mean +/- SEM. Similar results were obtained from separate experiments. *, P < 0.05. (D) CD86 expression on different MLN subsets. The gray histogram represents isotype control, the dotted histogram represents mock controls, and the black histogram represents infected animals. (E) Sorted DC subsets were stained for intracellular NP. Uninfected cells stain dull red because of Evan's blue in the solution, and the green fluorescence indicates NP. Bar, 20 mum. These images are representative of one experiment out of at least five performed. (F) Flow cytometric analysis of the total detectable amount of intracellular NP in DC subsets as a percentage of total live LN cells per DC subset. The values are representative of five mice per group and are expressed as mean +/- SEM. Similar results were obtained from two separate experiments. (G) Plots represent CFSE-labeled T cell proliferation 4 d after co-culture with the various sorted DC populations obtained from pooled LNs of 20 influenza-infected mice. (top) CD8+ T cells and (bottom) CD4+ T cell proliferation are shown. Numbers (top left corners) represent the percentage of cells recruited into cell division. Cell sortings with co-culture were performed three times each, and the results shown are representative plots of these experiments.
###end p 21
###begin p 22
###xml 158 165 158 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink">257-264</sub>
###xml 167 168 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 267 274 267 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink">323-339</sub>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 665 673 665 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 757 765 757 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 813 814 813 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 822 823 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 913 914 909 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 924 932 920 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 1008 1016 1004 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 G</xref>
###xml 1038 1046 1034 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 G</xref>
###xml 1066 1067 1062 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1075 1076 1067 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1148 1149 1140 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1157 1158 1145 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1267 1282 1255 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, E and F</xref>
###xml 1307 1308 1295 1296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 1454 1458 <span type="species:ncbi:10090">mice</span>
To test the antigen-presenting potential of the various DC subsets in the MLNs, mice were infected with influenza virus encoding either the immunodominant OVA257-264 Kb-restricted MHCI epitope recognized by the OT-I TCR-transgenic (Tg) strain (40) or carrying the OVA323-339 MHCII epitope recognized by the OT-II TCR-Tg strain (41), allowing us to probe presentation of sorted lung DC subsets to naive OVA-specific CD8 and CD4 T cells directly ex vivo. To have an indication of the uptake of viral antigen or virally infected apoptotic cells, preparations of sorted DC subsets from the MLNs were also stained for the presence of viral NP using a specific antibody (Fig. 3 E), and confirmed using eight-color flow cytometric staining on permeabilized cells (Fig. 3 F). Viral NP was found, particularly in the CD11b+CD8alpha- subset as well as abundantly in the pDC subset, and was practically absent from the CD11b- subsets (Fig. 3 F). When DC subsets were sorted and co-cultured with OVA-specific OTI cells (Fig. 3 G, top) or OTII cells (Fig. 3 G, bottom), the CD11b-CD8alpha- subset presented antigen to both CD8 and CD4 T cells, whereas the CD11b-CD8alpha+ resident DCs presented exclusively to CD8 cells. Despite the fact that these cells had seen viral antigens (Fig. 3, E and F, NP staining), the CD11b+ DCs and pDCs did not present antigen to naive CD4 or CD8 T cells. As a control, OT-I or OT-II T cells incubated with total MLN DCs obtained from mice infected with the virus containing the OVA-MHCII or -MHCI epitope, respectively, failed to proliferate.
###end p 22
###begin title 23
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
Conditional depletion of lung CD11chi cells aggravates features of infection
###end title 23
###begin p 24
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 318 320 318 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 336 337 336 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 417 425 417 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 503 504 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 539 540 539 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 726 727 726 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 735 736 731 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 754 756 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 758 760 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 785 787 781 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 865 867 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 869 871 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 1558 1566 1554 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 1786 1788 1782 1784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1876 1877 1872 1873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1945 1952 1941 1948 <sub xmlns:xlink="http://www.w3.org/1999/xlink">366-374</sub>
###xml 1965 1966 1961 1962 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2177 2185 2173 2181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 2386 2394 2378 2386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 1073 1077 <span type="species:ncbi:10090">mice</span>
###xml 1229 1233 <span type="species:ncbi:10090">mice</span>
###xml 1335 1339 <span type="species:ncbi:10090">mice</span>
###xml 1798 1802 <span type="species:ncbi:10090">mice</span>
DCs are extremely potent APCs that are uniquely suited to prime naive T cells. To study the immune response against influenza virus infection with and without CD11chi DCs, CD11c-DTR mice were treated with DT intratracheally (i.t.) 1 d before infection with influenza virus X-31. By this localized treatment, lung CD11chi DCs (both CD11b+ and CD11b-) and alveolar macrophages were efficiently depleted from the lungs (Fig. 4 A). In the trachea, the localized treatment with DT led to a reduction of CD11b+ DCs, but not to depletion of CD11b- DCs (Fig. S3 A, available at ) or pDCs (not depicted). In the MLNs, all DC subsets were partially depleted after DT treatment, with the biggest depletion occurring in the resident CD11b-CD8alpha+ DCs (Fig. S3 B) (19, 37). On the contrary, CD11chi cells in the spleen or nondraining LNs were not affected (unpublished data) (19, 37). At different time points after infection, the clinical immune response and viral replication were analyzed. First, clinical severity of infection was determined by measuring body weight. In general, mice show a maximal 10% weight loss after a mild X-31 infection and rapidly regain weight once the virus has been cleared from the lungs. When CD11c-DTR Tg mice were treated with DT before infection, the clinical severity of infection dramatically increased and mice lost up to 20% of their weight, representing a sublethal infection. This weight loss could not be attributed to DT treatment, as the control group, which was treated with DT before mock infection, did not lose weight (Fig. 4 B). As weight loss might be related to the initial severity of infection or failure of the immune system to clear infectious particles from the lung, we next studied the generation of an efficient immune response in CD11chi-depleted mice. For efficient lung clearance of a primary influenza virus infection, CD8+ CTLs play an important role. We therefore measured the number of NP366-374 peptide/H-2Db-specific CTL cells using tetramer reagents and correlated their numbers to viral clearance. In DT-treated and -infected animals, the number of virus-specific CTLs was significantly reduced in the lung, spleen (Fig. 4 C), and MLN (not depicted). In addition to the measurement of CTL, CD3-stimulated IFN-gamma production by CD4 and CD8 T cells from MLNs was determined and dramatically suppressed in the absence of DCs (Fig. 4 D).
###end p 24
###begin p 25
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Infection parameters after conditional depletion of CD11c<sup>hi</sup> cells in a CD11c-DTR Tg mouse model.</bold>
###xml 229 231 229 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 565 572 565 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink">peptide</sub>
###xml 577 578 577 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1129 1136 1121 1128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">peptide</sub>
###xml 1141 1142 1133 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 965 969 <span type="species:ncbi:10090">mice</span>
###xml 1007 1011 <span type="species:ncbi:10090">mice</span>
###xml 1274 1278 <span type="species:ncbi:10090">mice</span>
Infection parameters after conditional depletion of CD11chi cells in a CD11c-DTR Tg mouse model. CD11c-DTR Tg mice received an i.t. injection of DT on day -1, followed by X-31 i.n. infection. (A) Efficient depletion of lung CD11chi cells by DT treatment compared with PBS treatment. (right) Plots demonstrate flow cytometry data, and numbers indicate the percentage of live cells within each gate. (B) Body weight after influenza infection. A weight loss of 20% represents a sublethal infection. (C) Virus-specific CTL response in spleen and lung as measured by Flupeptide/H-2Db tetramer (TM) staining. (D) IFN-gamma levels in supernatants of MLN cell cultures restimulated with anti-CD3 antibody. (E) Viral titers measured in lung tissue after influenza X-31 infection. Virus is normally completely cleared at 8 dpi. nd, nondetectable. (F) IFN-alpha levels in BAL fluid. (G) Adoptive transfer of wild-type DCs and alveolar macrophages into DT-treated CD11c-DTR Tg mice before viral infection. CD11c-DTR Tg mice were either treated with PBS or DT, and received either DCs or macrophages before influenza infection. Numbers of Flupeptide/H-2Db-specific CTLs in spleen suspensions (left) and viral titer in lung tissue (right) are shown. The values are representative of five mice per group and are expressed as mean +/- SEM. Similar results were obtained from at least two separate experiments. *, P < 0.05; **, P < 0.01.
###end p 25
###begin p 26
###xml 209 217 209 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 262 264 262 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 295 296 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 301 303 297 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
As induction of virus-specific CTL responses is necessary for viral clearance from the lung, we measured viral titers in the lungs. In this mild infection model, virus is normally cleared completely at 8 dpi (Fig. 4 E) (42). However, in the absence of lung CD11chi cells and mediastinal CD8alpha+CD11chi cells, the virus had not been cleared at this time.
###end p 26
###begin p 27
###xml 389 390 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 392 393 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 507 509 499 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 532 533 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">,</italic>
###xml 629 631 617 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 648 656 636 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 F</xref>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
A delay in viral clearance could be caused by a direct defect in CTL priming but could also result from a less efficient innate response consisting mainly of type I IFN production. IFN-alpha has been described as an important antiviral cytokine that is mainly produced by epithelial cells and alveolar macrophages, but also by pDCs and even myeloid DCs after influenza infection in vitro (3, 5). We therefore determined IFN-alpha production in the BAL fluid at different time points after infection in CD11chi-depleted mice. In vivo, IFN-alpha was produced in the lungs after X-31 infection, but levels were not affected by CD11chi cell depletion (Fig. 4 F).
###end p 27
###begin p 28
###xml 47 49 47 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 367 369 367 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 424 426 424 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 531 539 531 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 G</xref>
###xml 617 625 617 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 G</xref>
###xml 766 768 766 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
The data in this paragraph show that lung CD11chi cells are required for an efficient immune response against influenza virus infection. However, as CD11c is also highly expressed by alveolar macrophages and these cells are also depleted by local i.t. administration of DT, we performed adoptive transfer reconstitution experiments (19, 37). Tg mice depleted of CD11chi cells therefore received i.t. unpulsed wild-type CD11chi DCs or alveolar macrophages at the moment of infection. DCs were capable of restoring the CTL response (Fig. 4 G), and as a consequence, viral clearance from the lung was complete by day 8 (Fig. 4 G, right). Alveolar macrophages were not capable of restoring antiviral immunity or viral clearance. These experiments demonstrated that CD11chi DCs are sufficient for inducing an adequate immune response against influenza virus infection.
###end p 28
###begin title 29
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Depletion of lung langerin+ DCs aggravates infection parameters
###end title 29
###begin p 30
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 123 124 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 168 170 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 385 386 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 391 393 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 436 437 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 478 480 478 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 558 559 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 564 565 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 720 721 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 729 730 721 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 777 778 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 841 849 833 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 921 929 913 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 973 981 965 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
The conditional depletion of CD11chi cells in CD11c-DTR mice did not allow us to address the contribution of tracheal CD11b-CD11chi DCs, as neither tracheal CD11b-CD11chi DCs nor their CD11b- progeny in the MLNs were depleted in CD11c-DTR mice. Therefore, we performed experiments in langerin-DTR mice. When DT was administered i.t. to these mice, there was a strong reduction in CD11b-CD11chi DCs in the trachea, whereas tracheal CD11b+ DCs were unaffected. In the lungs, CD11chi DCs were depleted, whereas alveolar macrophages were unaffected. The CD8alpha+CD11b- resident MLN cDC subset does not express langerin, and consequently, lung administration of DT to these mice only led to a reduction in lung-derived CD11b-CD8alpha- migratory DCs (Fig. S3). Depletion of langerin+ DCs resulted in a severe weight loss in the mice until 8 dpi (Fig. 5 B), and this was correlated with a significant decrease in CTL response (Fig. 5 C) and a deficient viral clearance at 8 dpi (Fig. 5 D).
###end p 30
###begin p 31
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of conditional depletion of langerin<sup>+</sup> DCs cells during influenza infection.</bold>
###xml 213 214 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 477 484 477 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink">peptide</sub>
###xml 489 490 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
Effect of conditional depletion of langerin+ DCs cells during influenza infection. Langerin-DTR Tg mice received an i.t. injection of DT on day -1, followed by X-31 i.n. infection. (A) Efficient depletion of MHCII+CD11c DCs in lung after DT treatment. Numbers indicate percentages of live cells within the gate. (B) Body weight after influenza infection. A weight loss of >20% represents a sublethal infection. (C) Virus-specific CTL response in spleen and lung measured by Flupeptide/H-2Db tetramer (TM) staining. (D) Viral titers measured in lung tissue after influenza X-31 infection. Virus is normally cleared completely at 8 dpi. The values are representative of five mice per group and are expressed as mean +/- SEM. Similar results were obtained from at least two separate experiments. *, P < 0.05; **, P < 0.01. nd, nondetectable.
###end p 31
###begin title 32
Depletion of pDCs did not alter the course of infection
###end title 32
###begin p 33
###xml 75 77 75 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 98 101 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 403 411 403 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 649 660 649 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, B&#8211;E</xref>
###xml 774 776 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 963 971 951 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 F</xref>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
The experiments using CD11c-DTR and langerin-DTR mice mainly depleted CD11chi cells, whereas CD11cint pDCs are globally not affected by this targeting strategy (43). To additionally address the role of pDCs, we performed experiments in which pDCs were depleted by injection of the 120G8 mAb (22). Using this antibody, an effective depletion of pDCs to <10% of baseline numbers was achieved in the lung (Fig. 6 A), as measured using antibodies directed against both bone marrow stromal antigen and SiglecH (24). Surprisingly, this efficient depletion of pDCs did not affect any of the infection parameters and virus was cleared efficiently by 8 dpi (Fig. 6, B-E). As pDCs have been previously described as the main IFN-alpha-producing cells in response to a viral infection (44), it was similarly striking that there was no reduction in the protein level of IFN-alpha in the BAL fluid or in the mRNA level for IFN-alpha in lung tissue after the depletion of pDCs (Fig. 6 F).
###end p 33
###begin p 34
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Infection parameters after influenza in mice depleted of pDCs.</bold>
###xml 389 396 389 396 <sub xmlns:xlink="http://www.w3.org/1999/xlink">peptide</sub>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 63 67 <span type="species:ncbi:10090">Mice</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
Infection parameters after influenza in mice depleted of pDCs. Mice received three i.p. injections of the depleting mAb 120G8 before infection with influenza on day 0. (A) Efficient depletion of lung pDCs after 3 d of 120G8 i.p. treatment compared with PBS treatment. (B) Body weight after infection. (C) Virus-specific CTL responses in spleen and lung cell suspensions, as measured by Flupeptide/H-2Db tetramer staining. (D) IFN-gamma levels in supernatants of MLN cell cultures restimulated with anti-CD3 antibody. (E) Viral titers in lung after influenza infection. (F) IFN-alpha levels in BAL fluid. The values are representative of five mice per group and are expressed as mean +/- SEM. Similar results were obtained from at least two separate experiments. *, P < 0.05; **, P < 0.01.
###end p 34
###begin title 35
###xml 89 91 89 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
The production of hemagglutinin (HA)-specific antibodies depends on pDCs and not on CD11chi DCs
###end title 35
###begin p 36
###xml 409 417 409 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 643 645 643 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 724 732 724 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
The induction of antiviral CD8 T cell responses is only one aspect of adaptive immunity to influenza. We also measured the production of serum HA-specific antibodies at 8 and 28 dpi by measuring HA inhibition (HI) titers. Although there was no effect on the induction of CD8 responses after 120G8-mediated pDC depletion, virus-specific antibody titers measured at both time points were significantly reduced (Fig. 7 A). We found no evidence for 120G8 staining on lung B cells, making it unlikely that this would be a depleting effect of 120G8 on B cells directly (unpublished data). Antibody responses were maintained in mice depleted of CD11chi DCs by DT treatment of CD11c-DTR mice 1 d before infection in CD11c-DTR mice (Fig. 7 B).
###end p 36
###begin p 37
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Virus-specific serum antibodies of influenza virus&#8211;infected mice after DC subset depletion.</bold>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
Virus-specific serum antibodies of influenza virus-infected mice after DC subset depletion. (A) Virus-specific antibodies in the serum of C57BL/6 mice after i.p. treatment with 120G8 depleting antibody or PBS, or (B) in the serum of CD11c-DTR mice after i.t. treatment with DT or PBS, measured at 8 dpi and 1 mo after infection. The values are representative of at least five mice per group and are expressed as geometric mean titer (GMT) of HI +/- SEM. The differences in HI titer can be explained by the background of the mice. CD11c-DTR mice were F1 (BALB/c x C57BL/6) animals and developed less high viral and HI titers than the pure C57BL/6 mice that were used in 120G8 depletion experiments. Similar results were obtained from at least two separate experiments. *, P < 0.05; **, P < 0.01.
###end p 37
###begin title 38
DISCUSSION
###end title 38
###begin p 39
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 88 89 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 120 121 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 129 130 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 194 195 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 213 215 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 217 219 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 311 312 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 395 396 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 493 494 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Belz et al. have elegantly described that after influenza infection, both CD11b-CD8alpha+ resident MLN DCs and the CD11b-CD8alpha- lung-derived migratory DC subset presented antigen to naive CD8+ T cells ex vivo (30, 32). However, these authors have not described in detail where exactly in the lung these CD11b- migratory DCs originated from and whether any of the DCs would also present to CD4+ T cells, and they have also not studied in detail the precise contribution of inflammatory CD11b+ DCs or pDCs that are recruited to inflamed lungs.
###end p 39
###begin p 40
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 241 247 241 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 337 338 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 343 344 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 386 387 386 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 392 393 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 398 399 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 407 408 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 474 475 470 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 480 481 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 535 536 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 541 542 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 726 727 722 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 779 781 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 783 785 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 923 925 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 956 957 952 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 962 963 958 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Our studies on the various anatomical lung compartments suggest that a predominant source of CD11b- DCs arriving in the MLNs are from the network of highly dendritic-shaped CD103+ intraepithelial DCs that lines the large conducting airways (Fig. 1) (18, 13). There was a marked decrease in this subset of highly dendriform tracheal CD11b-CD103+ DCs at 2 dpi, at a time that the langerin+CD103+CD11b-CD8alpha- DCs started to accumulate in the MLNs. The disappearance of CD11b-CD11c+ tracheal DCs was accompanied by a new influx of CD11b+CD11c+ DCs into the trachea (present as more rounded cells at day 2 after infection on whole mounts) and into the lung interstitium. These cells most likely differentiate from recruited Ly6C+ monocytes that give rise to inflammatory-type DCs (16, 45), or that arose from local proliferation and differentiation of a myeloid precursor population that also generates alveolar macrophages (46). An identical subset of CD11b+CD11c+ DCs was found to be increased in the MLNs from days 2 to 4 onwards, again suggesting migration from the lungs to the MLN.
###end p 40
###begin p 41
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 416 417 412 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 429 430 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 457 459 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 460 462 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
It was striking that there were several subsets of DCs found to be recruited and/or activated in the MLNs after influenza infection, strongly suggesting the division of labor between various APCs. Recently, several papers have shown that the cross presentation of exogenous harmless or viral antigen to CD8+ lymphocytes or presentation of exogenous antigen to CD4 T cells is a mutually exclusive function of CD8alpha+ or CD8alpha- DC subsets, respectively (47-49). We therefore performed a head-to-head comparison of the potential to present viral antigen to naive CD4 or CD8 T cells, taking advantage of influenza virus encoding either the MHCI or MHCII immunodominant OVA epitope.
###end p 41
###begin p 42
###xml 48 49 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 54 55 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 245 246 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 254 255 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 567 569 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 753 755 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 793 794 781 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 807 808 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 814 815 798 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1168 1169 1148 1149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1245 1246 1225 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1254 1255 1230 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1316 1318 1292 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 1373 1374 1349 1350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1554 1555 1526 1527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
As previously described by Belz et al., CD8alpha+CD11b- resident DCs presented viral antigen to naive CD8 cells, supported by the fact that these cells had up-regulated co-stimulatory molecules. Strikingly, the population of airway-derived CD11b-CD8alpha- DCs also up-regulated co-stimulatory molecules and presented not only to CD8 T cells but also to CD4 T cells. This suggests that processing for and presentation on both MHCI and MHCII molecules can occur in a single cell population in vivo in the lung, contrary to what was shown for the spleen or lymph nodes (30). Vermaelen et al. also previously demonstrated that antigen presentation of harmless antigen to naive CD4 T cells in the MLNs was an exclusive function of a migratory DC population (50). Despite the fact that both CD8alpha+ and CD8alpha- CD11b- DCs presented antigen to naive T cells, the strength of viral NP staining was not abundant. This could be explained by the fact that viral NP was digested in these subsets as part of an antigen-processing step, leading to a loss of immunoreactivity toward the NP-specific antibody. Alternatively, Belz et al. previously suggested that resident CD8alpha+ cells acquired the antigen from other migratory APCs, proposed as the CD11b-CD8alpha- lung-derived DCs, but this was never directly demonstrated (30). Our data on viral NP staining suggest that the CD11b+ DCs as well as the pDCs were abundantly positive for viral antigen in the MLNs and, therefore, could be the most important source for providing viral antigens to resident CD8alpha+ DCs.
###end p 42
###begin p 43
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 638 639 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 790 791 790 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 964 966 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 982 983 982 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1132 1153 1128 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Listera monocytogenes</italic>
###xml 1165 1167 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 1169 1171 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 1196 1197 1192 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1491 1492 1487 1488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1504 1506 1500 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 1508 1509 1504 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 1640 1641 1636 1637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Another striking observation was the fact that the CD11b+CD11c+ subset found to be increased in the trachea, lung, and MLNs after influenza infection hardly presented any viral antigen to CD4 or CD8 T cells. Clearly, the CD11b+ DCs had seen viral antigens (either directly or through phagocytosis of virally infected apoptotic epithelial cells) as they carried an abundant amount of viral NP in their cytoplasm. The absence of APC function by this subset is in striking contrast to the situation when harmless noninflammatory antigen is inhaled (15). What could be the purpose of recruitment of a different DC subset, in addition to CD11b- DCs, if these cells do not present antigen to naive T cells? First, as these cells have been shown to massively produce inflammatory chemokines, CD11b+ DCs might be crucial in attracting effector CD4 and CD8 cells that have been generated in the LNs back to the lung and trachea, where they would mediate effector function (51). Second, CD11b+ DCs might have direct innate antiviral activity by producing TNF-alpha and inducible NO synthase-dependent NO, analogous to the situation seen with Listera monocytogenes infection (52, 53). Third, recruited CD11b+ DCs might also stimulate the innate antiviral activity of NK cells. The important function of inflammatory DCs in initiating the innate response is supported by the fact that influenza produces the nonstructural protein 1, with a specific aim to subvert the innate immune function of the CD11b+ DC subset (54, 3). Future studies in our laboratory will have to address the direct or indirect innate and adaptive functions of inflammatory CD11b+ DCs in influenza infection.
###end p 43
###begin p 44
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 310 312 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 335 336 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 341 343 341 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 377 378 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 383 385 379 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 404 405 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 410 412 406 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 517 518 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 526 527 518 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 609 610 601 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 783 785 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 856 857 840 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 862 864 846 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 922 923 906 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 934 936 918 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 989 993 <span type="species:ncbi:10090">mice</span>
Another way to study the function of lung DC subsets is to deplete them using various cell-specific genetic targeting strategies using expression of the DTR under control of a specific promoter and administration of the DT via the airways (19). In CD11c-DTR mice, there is a predominant depletion of lung CD11chi DCs, of tracheal CD11b+CD11chi DCs, and of resident MLN CD8alpha+CD11chi DCs. Because CD11b-CD11chi migratory tracheal DCs are not depleted in these mice, we consequently observed no decrease in MLN CD11b-CD8alpha- DCs. In CD11c-DTR mice given DT, we noticed that generation of virus-specific CD8+ CTLs and production of effector cytokines (IFN-gamma) by MLN cells was severely diminished. Based on our antigen presentation studies and the previous work of Belz et al. (30), we propose that this is caused by depletion of the resident CD8alpha+CD11chi DCs or to the depletion of chemokine-producing lung CD11b+ DCs. CD11chi alveolar macrophages are also depleted in CD11c-DTR mice, although it is unlikely that this contributed to a decrease in antiviral immunity, as adoptive transfer of wild-type DCs but not macrophages restored immunity.
###end p 44
###begin p 45
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 183 184 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 345 346 345 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 357 358 357 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 363 364 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 481 482 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 490 491 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 549 550 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 655 656 647 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 662 663 654 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 776 777 768 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 839 840 831 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 883 885 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 887 889 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 891 893 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
To address the specific role of migratory tracheal CD11b- DCs, we performed experiments in langerin-DTR mice (36). Langerin was found to be particularly present on mucosal CD11b-CD103+ DCs in the lung (13), a population of cells that strictly relies on CCR7 to migrate to the MLNs (15). In accordance, we also found increased numbers of langerin+CD103+CD11b-CD11c+ DCs in the MLNs after influenza infection. After i.t. administration of DT, there was a selective depletion of CD11b-CD8alpha- migratory DCs in the trachea and MLNs, while the CD8alpha+ resident LN population or alveolar macrophages were unaffected. In the absence of the migratory langerin+ CD11b- DC population, influenza ran a particularly severe course. Strikingly, these data also suggest that the langerin+ DCs of the lung are much more immunogenic than their langerin+ Langerhans cell counterparts in the skin (55, 36, 56).
###end p 45
###begin p 46
###xml 117 119 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 224 226 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 316 318 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 468 470 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 922 924 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 926 928 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 930 932 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1796 1797 1772 1773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 2047 2049 2023 2025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
###xml 125 131 <span type="species:ncbi:9606">humans</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
Finally, we also addressed the in vivo function of lung pDCs, previously known as natural IFN-alpha-producing cells (44). In humans, these cells produce copious amounts of IFN-alpha when exposed to influenza virus in vitro (57) and have been shown to stimulate already-primed influenza-specific CD4 and CD8 T cells (34). It has therefore been suggested that upon proper stimulation, pDCs develop into bona fide APCs that primarily stimulate antiviral immune response (58). To address the antigen-presenting function of pDCs, we sorted pDCs from the MLNs of infected mice and found no evidence for presentation to either CD4 or CD8 T cells ex vivo, despite the fact that the cells contained copious amounts of intracellular viral NP. Previous studies with other respiratory viruses have suggested that pDCs have a more immunoregulatory role, which is crucial for preventing excessive immune activation and immunopathology (12, 24, 25). Although pDCs were attracted to the lungs and tracheal wall during influenza infection, their confirmed depletion using 120G8 antibody did not affect viral titers, generation of virus-specific T cells, or the severity of infection, arguing against a predominant role for pDCs as APCs, immunoregulatory cells, or innate immune cells in this mild infection model. It was similarly striking to see that there was no effect on IFN-alpha production when pDCs were effectively depleted. Infections in epithelial surfaces that bathe in IFN-alpha (produced by epithelial cells) might be less dependent on IFN-alpha production by pDCs. Kumagai et al. recently demonstrated that during lung infection with RNA viruses, alveolar macrophages are a predominant source of type I IFN, and that pDCs only start producing IFN-alpha when macrophages are depleted from the lungs (5). The only effect of treatment with the 120G8 antibody was a significant reduction of the titer of virus-specific HI antibodies at 8 and 28 dpi, signifying a possible role for pDCs in stimulating humoral antiviral immunity, as previously suggested (59). Although we found no evidence for 120G8 staining on lung B cells after influenza infection, treatment with 120G8 antibody could also deplete plasma cells directly and in this way reduce HI antibody titers. Therefore, we are awaiting more specific (e.g., genetic) pDC targeting strategies to address this point further. In conclusion, our paper demonstrates a division of labor between different DC subsets during pulmonary influenza infection, knowledge that might be used for the design of better influenza vaccines and could increase our understanding of why particular strains of influenza are more pathogenic than others.
###end p 46
###begin title 47
MATERIALS AND METHODS
###end title 47
###begin title 48
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 48
###begin p 49
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 179 180 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 216 217 216 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 272 273 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 289 291 289 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
6-8-wk-old C57BL/6 mice were purchased from Harlan. The generation and screening of CD11c-DTR Tg mice has been previously described (37). Male BALB/c background CD11c-DTR Tg (H2-Dd) mice were crossed to C57BL/6 (H2-Db), to obtain F1 progeny, to allow detection of the H2-Db tetramer. CD11chi cells were depleted in CD11c-DTR x C57BL/6 Tg mice by i.t. injection of 50 ng DT, a dose previously determined by titration (15). pDCs were depleted by i.p. injection of pDC-selective depleting 120G8 antibody (22). All experiments were approved by an independent animal ethics committee of Erasmus Medical Centre Rotterdam.
###end p 49
###begin title 50
Influenza virus infection.
###end title 50
###begin p 51
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">60</xref>
###xml 589 590 582 583 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 659 660 651 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 844 846 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">60</xref>
###xml 952 959 944 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink">257-264</sub>
###xml 961 962 953 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1005 1007 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 1056 1063 1048 1055 <sub xmlns:xlink="http://www.w3.org/1999/xlink">323-339</sub>
###xml 1098 1100 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 111 118 <span type="species:ncbi:9031">chicken</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
###xml 1155 1163 <span type="species:ncbi:9606">Children</span>
Influenza virus X-31 (Medical Research Council) was inoculated in the allantoic cavity of 11-d-old embryonated chicken eggs. The allantoic fluid was harvested after 2 d. Infectious virus titers were determined in Madin-Darby canine kidney (MDCK) cells (NBL-2; American Type Culture Collection), as described previously (60). Virus titers were obtained at days 4 and 8 after infection. Lungs were stored at -70degreesC. Lungs were homogenized with a homogenizer (Polytron; Kinematica AG) in infection medium (Eagle's minimal essential medium), 0.3% BSA (fraction V), 4 mug/ml trypsin, 2 mM l-glutamine, 100 U/ml penicillin, 100 mug/ml streptomycin, 0.15% NaHCO3, 20 mM Hepes, and 0.1 mM of nonessential amino acids. 10-fold serial dilutions of these samples were used 8-fold to determine the virus titers in MDCK cells, as described previously (60). For antigen presentation assays of LN DCs, mice were infected with WSN influenza virus encoding the OVA257-264 Kb-restricted MHCI epitope in neuraminidase (40), and with X-31 influenza virus encoding the OVA323-339 MHCII epitope in HA of the virus (41). The OVA viruses were provided by R. Webby (St. Jude Children's Research Hospital, Memphis, TN).
###end p 51
###begin title 52
Flow cytometry.
###end title 52
###begin p 53
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
For detection and phenotyping of DCs at days 2, 4, and 10 after infection, single-cell suspensions of MLNs and lung samples were prepared as described previously (24). Trachea was digested in collagenase solution for 1 h at 37degreesC to promote the release of DCs. Cells were subsequently stained with mAbs directed against MHCII FITC, intracellular NP FITC, CD86 PE, CD11c PE Texas red, CD45 PECy5, CD103 PECy7, intracellular langerin APC, mPDCA-1 APC, F4/80 APC Cy7, CD11b Pacific blue, and a fixable live/dead marker in Aqua (Invitrogen). Acquisition of eight to nine color samples was performed on a cytometer (FACSAria) equipped with FACSDiva software (both from BD Biosciences). The final analysis and graphical output were performed using FlowJo software (Tree Star, Inc.). Cell sorting of DC subsets from MLNs was performed on a FACSAria. The purity of sorted populations was >95%.
###end p 53
###begin title 54
Immunofluorescence on sorted DC subsets.
###end title 54
###begin p 55
Sorted cell populations were spotted on microscope slides, dried, and fixed in acetone. Subsequently, the slides were incubated with FITC-labeled influenza A NP-specific antibody (IMAGEN influenza virus; Dako) at 37degreesC for 15 min. The slides were washed twice with PBS and once with distilled water, dried, and embedded into a glycerol-PBS solution (Citifluor; UKC Chemlab). Uninfected cells stain dull red because of the Evan's blue in the solution. Green and yellow signals indicate the presence of NP. Fluorescence was scored using a fluorescence microscope (LSM 510; Carl Zeiss, Inc.).
###end p 55
###begin title 56
Analysis of T cell proliferation.
###end title 56
###begin p 57
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 563 564 563 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 564 565 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 567 568 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 568 569 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 572 573 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 573 574 573 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 580 581 580 581 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 586 587 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 587 588 587 588 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 593 594 593 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 594 595 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 601 602 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 602 603 602 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink">5</sub>
###xml 609 610 609 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 610 611 610 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 617 618 617 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 618 619 618 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
OT-1 and OT-2 Tg T cells were isolated from spleens and LNs of respective mice, enriched by MACS cell sorting with anti-CD8 or -CD4 antibodies according to manufacturer's protocol (Miltenyi Biotec), and labeled with CFSE (61). Sorted DC subsets were co-cultured with T cells in a v-bottom plate at a 1:10 ratio for 4 d. T cell divisions were measured by flow cytometry. The percentage of cells recruited into each cell division was calculated by dividing the number of individual cells by CFSE content, as previously described (61), using the formula 100 x {1 - [n0/(n0 + n1/2 + n2/4 + n3/8 + n4/16 + n5/32 + n6/64 + n7/128)] } to correct for the multiplying effect of division.
###end p 57
###begin title 58
Tracheal whole mount staining.
###end title 58
###begin p 59
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 456 461 456 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b,d,k</sup>
###xml 388 394 <span type="species:ncbi:9986">rabbit</span>
###xml 429 432 <span type="species:ncbi:10116">rat</span>
###xml 563 569 <span type="species:ncbi:9986">rabbit</span>
###xml 575 578 <span type="species:ncbi:10116">rat</span>
Animals were anesthetized with a lethal dose of Nembutal (Sanofi) and perfused in vivo with 1% paraformaldehyde fixative in PBS, pH 7.4, for 2 min through the ascending aorta (18). Tracheas were removed, opened by a midline incision, and pinned flat in silicone-coated Petri dishes. After permeabilization in PBS containing 0.3% Triton X-100 (Sigma-Aldrich), tissues were preblocked with rabbit serum, incubated with M5/114 mAb (rat IgG2, anti-I-A, and I-Eb,d,k; Boehringer Mannheim) for 36 h at room temperature, washed, and incubated with peroxidase-conjugated rabbit anti-rat IgG, followed by incubation for 20 min in 0.05% diaminobenzidine in Tris-buffered saline, pH 7.6. Tissues were dehydrated in serial alcohol steps and cleared in toluene. The entire trachea was mounted in DPX mounting medium.
###end p 59
###begin title 60
Detection of virus-specific CTL by tetramer-staining.
###end title 60
###begin p 61
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 372 373 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 394 401 394 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink">366&#8211;374</sub>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
Single-cell suspensions of lung and spleen samples were prepared as described previously (24). Red blood cells were removed using erythrocyte lysis buffer (Roche). The cells were washed with 0.5% BSA in PBS and stained for 20 min at room temperature with the following antibodies: CD3e-PerCP and CD8b.2-FITC (BD Biosciences), TO-PRO 3-APC (Invitrogen), and PE-labeled H-2Db tetramer with the NP366-374 epitope ASNENMETM (Sanquin Research) (62).
###end p 61
###begin title 62
Effector cytokine production.
###end title 62
###begin p 63
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
On day 4 after infection, single-cell suspensions of lung draining LNs were prepared. Cells were cultured in RPMI 1640 medium with 5% FCS at a concentration of 2 x 106 cells/ml in the presence of either 1 mug/ml of plate-bound anti-CD3 (BD Biosciences) or medium alone and incubated at 37degreesC. After 4 d, supernatants were collected and stored at -20degreesC until ELISA for IFN-gamma (BD Biosciences) was performed. IFN-alpha ELISA (PBL Biomedical Laboratories) was performed on BAL fluid on several days after infection. Quantitative RT-PCR for IFN-alpha was performed on homogenized lungs on day 4 after infection (Assay-On-Demand; Applied Biosystems).
###end p 63
###begin title 64
Generation of bone marrow-derived DCs.
###end title 64
###begin p 65
###xml 287 289 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 248 253 <span type="species:ncbi:10090">mouse</span>
Bone marrow cells were cultured for 9 d in DC culture medium (RPMI 1640 containing glutamax-I; Invitrogen) supplemented with 5% (vol/vol) FCS (Sigma-Aldrich), 50 muM 2-ME (Sigma-Aldrich), 50 mug/ml gentamicin (Invitrogen), and 20 ng/ml recombinant mouse GM-CSF, as previously described (15).
###end p 65
###begin title 66
Adoptive transfer.
###end title 66
###begin p 67
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 198 199 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Adoptive transfer reconstitution experiments were performed in DT-treated CD11c-DTR x C57BL/6 mice. At the moment of infection, they were treated i.t. with 2 x 106 bone marrow-derived DCs and 2 x 105 alveolar macrophages, as previously described (19).
###end p 67
###begin title 68
Detection of virus-specific antibodies in serum.
###end title 68
###begin p 69
###xml 281 283 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib63">63</xref>
###xml 225 231 <span type="species:ncbi:9103">turkey</span>
After treatment with cholera filtrate and heat inactivation at 56degreesC, the serum samples were tested for the presence of anti-HA antibodies. For this purpose, an HI assay was used according to the standard protocol of 1% turkey erythrocytes and 4 HA U of H3N2 influenza virus (63).
###end p 69
###begin title 70
Statistical analysis.
###end title 70
###begin p 71
All experiments were performed using 5-10 animals per group. The difference between groups was calculated using the Mann-Whitney U test for unpaired data (Prism software version 4.0; GraphPad Software, Inc.). Differences were considered significant when P < 0.05.
###end p 71
###begin title 72
Online supplemental material.
###end title 72
###begin p 73
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows time kinetics of neutrophils, B cells, and CD8+ T cells in the lung after influenza infection. Fig. S2 shows the gating strategy for myeloid DCs (A), pDCs (B), and alveolar macrophages (C). Fig. S3 shows the depletion of DC subsets in the tracheas (A) and MLNs (B) in CD11c-DTR (left) and langerin-DTR (right) mice. Online supplemental material is available at .
###end p 73
###begin title 74
Supplementary Material
###end title 74
###begin title 75
[Supplemental Material Index]
###end title 75
###begin p 76
C.H. GeurtsvanKessel is supported by a Viral Genomics (VIRGO) grant from the Netherlands Organisation for Scientific Research. L..S. van Rijt is supported by an Erasmus University Rotterdam fellowship, and B.N. Lambrecht is supported by VIDI and VIRGO grants from the Netherlands Organisation for Scientific Research, as well as by an Odysseus Grant from the Flemish government. M. Kool is supported by a grant from the Dutch Asthma foundation. B.E. Clausen is the recipient of a VIDI grant and a career development grant from the Landsteiner Foundation for Blood Transfusion Research.
###end p 76
###begin p 77
The authors have no conflicting financial interests.
###end p 77

